Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Dementia Action Week: the challenges of treating a multifaceted condition

Dementia refers to a large group of diseases that affect the brain. The most common form is Alzheimer’s, making it, unsurprisingly, the main target of pharma R&D. As these treatments are largely ineffective for other forms of dementia with various causes, there is a significant need for new treatment options.


Go Top